Thought Leader Theater™ Presentations

The Heart of Innovation Thought Leader Theater™ featured presentations and panel discussions from world-renowned physicians, scientists and academics that are on the front lines of advances in care for patients with coronary artery disease and heart failure. These presentations correlate to the four Galleries of the Heart of Innovation: Personalized Medicine, TechnoBiology, Minimally Invasive Procedures and Physician-Patient Engagement.

These presentations will be available to view in May. Please check back then.

Pharmacogenetic Development and Targeting of Cardiovascular Drugs
Michael R. Bristow, MD, PhD, FACC, FAHA—CU Cardiovascular Institute, University of Colorado-Anschutz Medical Campus; Aurora, CO

Moderated Discussion: Role of Genetics and Proteomics and
How They Will Alter the Management of Heart Disease
Moderator: Jennifer L. Hall, PhD, FACC, FAHA—University of Minnesota; Lillehei Heart Institute Developmental Biology Center; Minneapolis, MN
Panelist: Robert Roberts, MD, MACC, FACP, FAHA, FESC, FISHR, FRCPC, FRSM—University of Ottawa Heart Institute; Ottawa Heart Institute Research Corporation; Ruddy Canadian Cardiovascular Genetics Centre; University of Ottawa; Ottawa, ON, Canada
Panelist: Jennifer E. Van Eyk, PhD—Johns Hopkins NHLBI Proteomics Center, Johns Hopkins School of Medicine; Baltimore, MD

Biomarker Guided Heart Failure Management
James L. Januzzi, Jr., MD, FACC—Massachusetts General Hospital; Harvard Medical School; Boston, MA

Personalized Medicine and Coronary Artery Disease
Robert Roberts, MD, MACC, FACP, FAHA, FESC, FISHR, FRCPC, FRSM—University of Ottawa Heart Institute; Ottawa Heart Institute Research Corporation; Ruddy Canadian Cardiovascular Genetics Centre; University of Ottawa; Ottawa, ON, Canada

Applying Personalized Medicine in the Cath Lab by Tailoring Treatment to Patient Risks
John A. Spertus, MD, MPH, FACC—University of Missouri; Mid America Heart Institute; Kansas City, MO

Stem Cells and Biomatrixes
Anthony N. DeMaria, MD, MACC—Sulpizio Cardiovascular Center, University of California, San Diego; San Diego, CA

Moderated Discussion: A New Approach to Delivering Stem Cell Therapy for Patients with CHF
Moderator: Anthony N. DeMaria, MD, MACC—Sulpizio Cardiovascular Center, University of California, San Diego; San Diego, CA
Panelist: Bernard J. Gersh, MB, ChB, DPhil, FACC—Mayo Clinic; Rochester, MN
Panelist: Andreas M. Zeiher, MD—University of Frankfurt; Frankfurt, Germany

Current Status and Future Direction of Stem Cell Therapy for Cardiovascular Disease
Nabil Dib, MD, MSc, FACC—Heart Sciences Center; University of California, San Diego; Celebration Stem Cell Centre; International Society for Cardiovascular Translational Research; Phoenix, AZ

Cell Therapy for Chronic Ischemic Heart Disease from Concept to Clinic
Joshua M. Hare, MD, FACC, FAHA—Interdisciplinary Stem Cell Institute University of Miami Miller School of Medicine; Miami, FL

Autologous Stem Cells Therapy for the Treatment of Refractory Angina
Timothy D. Henry, MD, FACC—Minneapolis Heart Institute Foundation; Minneapolis Heart Institute/Abbott Northwestern Hospital; University of Minnesota School of Medicine; Minneapolis, MN

Heart-Derived Cells for the Treatment of Myocardial Infarction
Eduardo Marbán, MD, PhD, FACC—Cedars-Sinai Heart Institute; Los Angeles, CA

The Regulatory Pathway of Cellular Therapy
Steve Winitsky, MD—U.S. Food and Drug Administration; Rockville, MD

Role of Real-Time 3D TEE Integration for Complex Transcatheter SHD Repairs
John D. Carroll, MD, FACC, FSCAI—University of Colorado; University of Colorado Hospital; Aurora, CO

Transcatheter Aortic Valve Replacement: Where Are We and Where Do We Go?
G. Alain Cribier, MD—University Hospital Charles Nicolle; Rouen, France

The Evolution of Radiation Protection
Christian E. Machado, MD, FACC, FAHA, FHRS—Wayne State University School of Medicine; Heart Cardiology Consultants; Providence Hospital; Detroit, MI

Moderated Discussion: Viability of Robotic TECAB
Moderator: James B. McClurken, MD, FACC, FACS, FCCP, FESC—Temple University Health System; Philadelphia, PA
Panelist: Johannes O. Bonatti, MD, FETCS—University of Maryland Medical Center; Baltimore, MD
Panelist: Ralph J. Damiano, Jr., MD, FACC—Washington University in St. Louis School of Medicine; St. Louis, MO

Devices Used for Heart Failure
Leslie W. Miller, MD, FACC—University of South Florida; Tampa, FL

Robotic-Assisted PCI: Opportunities for Improved Precision and Efficiency
George W. Vetrovec, MD, FACC, FSCAI—VCU Pauley Heart Center at Virginia Commonwealth University; Virginia Commonwealth University Health System; Richmond, VA

Digital Intervention
JoAnne M. Foody, MD, FACC, FAHA—Brigham and Women’s Hospital; Boston, MA

ePHR COPE—The Use of PHR to Engage Patients Post-Coronary Revascularization
Michael J. Mirro, MD, FACC, FACP—Fort Wayne Cardiology; Fort Wayne, IN

Physician-Patient Engagement and Shared Decision Making
John R. Windle, MD, FACC—University of Nebraska Medical Center; Omaha, NE

Thought Leader Theater presentations were not part of the official ACC Annual Scientific Session & Expo and/or ACC-i2 with TCT, as planned by their Program Committees. Thought Leader Theater presentations do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.